Old Web
English
Sign In
Acemap
>
Paper
>
P441 Efficacy of biosimilar infliximab CT-P13 among inpatients with severe steroid-refractory colitis
P441 Efficacy of biosimilar infliximab CT-P13 among inpatients with severe steroid-refractory colitis
2020
Jacob E. Ollech
Inessa Normatov
Sujaata Dwadasi
Sushila Dalal
Dejan Micic
Amanda Israel
J Labas
P Joel
R D Cohen
David T. Rubin
S Atsushi
Keywords:
Physical therapy
Steroid
Gastroenterology
Refractory
Internal medicine
Diabetes mellitus
Infliximab
Colitis
Medicine
Biosimilar
Biosimilar Pharmaceuticals
Adverse effect
Inflammatory bowel disease
Ulcerative colitis
Crohn's disease
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]